Steroids, reproductive endocrine function, and affect: A review

Minerva Ginecologica

Volumn 61, Issue 6, 2009, Pages 541-562

  Frye, C A ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Androgens; Anxiety; Depression; Estrogens; Menopause; Progesterone

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; ANDROGEN; ANDROSTANOLONE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; GESTAGEN; HYDROCORTISONE; PROGESTERONE; STEROID 5ALPHA REDUCTASE;

AFFECT; AGING; AMYGDALOID NUCLEUS; ANXIETY; DEPRESSION; DIESTRUS; ENDOCRINE FUNCTION; HIPPOCAMPUS; HORMONE SUBSTITUTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIMBIC SYSTEM; MENOPAUSE; MOUSE; NEUROPROTECTION; NONHUMAN; OVARIECTOMY; POSTMENOPAUSE; PREMENSTRUAL DYSPHORIC DISORDER; PROESTRUS; RAT; REPRODUCTION; REVIEW; STRESS;

ADULT; AFFECT; AGED; ANDROGENS; ANIMALS; ANXIETY; BRAIN; DEPRESSION; ESTRADIOL; FEMALE; GONADAL STEROID HORMONES; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MENOPAUSE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; PROGESTINS; RATS; REPRODUCTION;

EID: 77949646004     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (227)

1. Cunningham GR, Tindall DJ, Means AR. Differences in steroid specificity for rat androgen binding protein and the cytoplasmic receptor. Steroids 1979;33:261-76.
2. Iswari S, Colas AE, Karavolas HJ. Binding of 5 alphadihydroprogesterone and other progestogens to female rat anterior pituitary nuclear extracts. Steroids 1986;47:189-203.
3. Gee KW. Steroid modulation of the GABA/benzodiazepine receptor-linked chloride ionophore. Mol Neurobiol 1988;2:291-317.
4. Sheridan PJ. Localization of androgen- and estrogen-concentrating neurons in the diencephalon and telencephalon of the mouse. Endocrinology 1978;103: 1328-34.
5. Shughrue PJ, Merchenthaler I. Distribution of estrogen receptor beta immunoreactivity in the rat central nervous system. J Comp Neurol 2001;436:64-81.
6. Brunner RL, Gass M, Aragaki A, Hays J, Granek I, Woods N et al. Women's Health Initiative Investigators. Effects of conjugated equine estrogen on health-related quality of life in postmenopausal women with hysterectomy: results from the Women's Health Initiative Randomized Clinical Trial. Arch Intern Med 2005;165: 1976-86.
7. Hays J, Ockene JK, Brunner RL, Kotchen JM, Manson JE, Patterson RE et al. Women's Health Initiative Investigators. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003;348: 1839-54.
8. Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE et al. WHIMS Investigators. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003;289:2663-72.
9. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML et al. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
10. Shumaker SA, Legault C, Thal L, Wallace RB, Ockene JK, Hendrix SL et al. WHIMS Investigators. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003;289:2651-62.
11. Smoller JW, Pollack MH, Wassertheil-Smoller S, Barton B, Hendrix SL, Jackson RD et al. Women's Health Initiative Investigators. Prevalence and correlates of panic attacks in postmenopausal women: results from an ancillary study to the Women's Health Initiative. Arch Intern Med 2003;163:2041-50.
12. Nicholas JS, Charles JM, Carpenter LA, King LB, Jenner W, Spratt EG. Prevalence and characteristics of children with autism-spectrum disorders. Ann Epidemiol 2008;18:130-6.
13. Rucklidge JJ. Gender differences in ADHD: implications for psychosocial treatments. Expert Rev Neurother 2008;8:643-55.
14. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatr 1994;51:8-19.
15. Weissman MM, Klerman GL. Sex differences and the epidemiology of depression. Arch Gen Psychiatr 1977;34:98-111.
16. Wittchen HU, Hoyer J. Generalized anxiety disorder: nature and course. J Clin Psychiatr 2001;62:15-9.
17. Angold A, Costello EJ, Erkanli A, Worthman CM. Pubertal changes in hormone levels and depression in girls. Psychol Med 1999;29:1043-53.
18. Soares CN, Cohen LS, Otto MW, Harlow BL. Characteristics of women with premenstrual dysphoric disorder (PMDD) who did or did not report history of depression: a preliminary report from the Harvard Study of Moods and Cycles. J Womens Health Gend Based Med 2001;10:873-8.
19. Chaudron LH, Klein MH, Remington P, Palta M, Allen C, Essex MJ. Predictors, prodromes and incidence of postpartum depression. J Psychosom Obstet Gynaecol 2001;22:103-12.
20. Freeman MP, Helgason C, Hill RA. Selected integrative medicine treatments for depression: considerations for women. J Am Med Womens Assoc 2004;59:216-24.
21. Klaiber EL, Broverman DM, Vogel W, Kobayashi Y. Estrogen therapy for severe persistent depressions in women. Arch Gen Psychiatr 1979;36:550-4.
22. Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JE, Sherwin BB et al; Women's Health Initiative Memory Study. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004;291:2959-68.
23. Henderson VW, Paganini-Hill A, Miller BL, Elble RJ, Reyes PF, Shoupe D et al Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology 2000;54:295-301.
24. Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC et at.; Cache County Memory Study Investigators. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 2002;288:2123-9.
25. Theisen C. IOM report targets testosterone therapy. J Natl Cancer Inst 2004;96:259.
26. Santoro N, Torrens J, Crawford S, Allsworth JE, Finkelstein JS, Gold EB etal. Correlates of circulating androgens in mid-life women: the study of women's health across the nation. J Clin Endocrinol Metab 2005;90:4836-45.
27. Breslau N, Schultz L, Peterson E. Sex differences in depression: a role for preexisting anxiety. Psychiatr Res 1995;58:1-12.
28. Schneier FR, Johnson J, Hornig CD, Liebowitz MR, Weissman MM. Social phobia. Comorbidity and morbidity in an epidemiologic sample. Arch Gen Psychiatr 1992;49:282-8.
29. Seeman MV. Psychopathology in women and men: focus on female hormones. Am J Psychiatr 1997;154:1641-7.
30. Earls F. Sex differences in psychiatric disorders: origins and developmental influences. Psychiatr Dev 1987;5:1-23.
31. Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB. Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. J Affect Disord 1993;29:85-96.
32. Nolen-Hoeksema S. Sex differences in unipolar depression: evidence and theory. Psychol Bull 1987;101:259-82.
33. Hayward C, Sanborn K. Puberty and the emergence of gender differences in psychopathology. J Adolesc Health 2002;30:49-58.
34. Kessler RC, Walters EE. Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the National Comorbidity Survey. Depress Anxiety 1998;7:3-14.
35. Lewinsohn PM, Rohde P, Seeley JR. Major depressive disorder in older adolescents: prevalence, risk factors, and clinical implications. Clin Psychol Rev 1998;18:765-94.
36. Young EA, Midgley AR, Carlson NE, Brown MB. Alteration in the hypothalamic-pituitary-ovarian axis in depressed women. Arch Gen Psychiatr 2000;57:1157-16.
37. Bebbington P, Hurry J, Tennant C, Sturt E, Wing JK. The epidemiology of mental disorders in Camberwell. Psychol Med 1981;11:561-79.
38. Bloch M, Daly RC, Rubinow DR. Endocrine factors in the etiology of postpartum depression. Compr Psychiatr 2003;44:234-46.
39. Jenkins R. Sex differences in depression. Br J Hosp Med 1987;38:485-6.
40. Rubinow DR, Schmidt PJ. The neuroendocrinology of menstrual cycle mood disorders. Ann NY Acad Sci 1995;771:648-59.
41. Dean C, Kendell RE. The symptomatology of puerperal illnesses. Br J Psychiatr 1981;139:128-33.
42. Dalton K. Menstruation and acute psychiatric illnesses. Br Med J 1959;34:148-9.
43. Baca-Garcia E, Diaz-Sastre C, de Leon J, Saiz-Ruiz J. The relationship between menstrual cycle phases and suicide attempts. Psychosom Med 2000;62:50-60.
44. Burger HG, Dudley EC, Hopper JL, Shelley JM, Green A, Smidi A et al. The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J Clin Endocrinol Metab 1995;80:3537-45.
45. Daly RC, Danaceau MA, Rubinow DR, Schmidt PJ. Concordant restoration of ovarian function and mood in perimenopausal depression. Am J Psychiatr 2003;160:1842-6.
46. Santoro N, Brown JR, Adel T, Skurnick JH. Characterization of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab 1996;81:1495-501.
47. Schmidt PJ, Haq N, Rubinow DR. A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women. Am J Psychiatr 2004;161:2238-244.
48. Bebbington PE, Dunn G, Jenkins R, Lewis G, Brugha T, Farrell M et al. The influence of age and sex on the prevalence of depressive conditions: report from the National Survey of Psychiatric Morbidity. Psychol Med 1998;28:9-19.
49. Goodwin FK, Jamison KR. Manic-depressive illness. Oxford University Press: New York, NY. Depressive conditions: report from the National Survey of Psychiatric Morbidity. Psychol Med 1990;28:9-19.
50. Weissman MM, Olfson M. Depression in women: implications for health care research. Science 1995;269:799-801.
51. Almeida OP, Lautenschlager N, Vasikaram S, Leedman P, Flicker L. Association between physiological serum concentration of estrogen and the mental health of community-dwelling postmenopausal women age 70 years and over. Am J Geriatr Psychiatr 2005;13:142-9.
52. Ditkoff EC, Crary WG, Cristo M, Lobo RA. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 1991;78: 991-5.
53. Heinrich AB, Wolf OT. Investigating the effects of estradiol or estradiol/progesterone treatment on mood, depressive symptoms, menopausal symptoms and subjective sleep quality in older healdiy hysterectomized women: a questionnaire study. Neuropsychobiology 2005;52:17-23.
54. Miller KJ, Conney JC, Rasgon NL, Fairbanks LA, Small GW. Mood symptoms and cognitive performance in women estrogen users and nonusers and men. J Am Geriatr Soc 2002;50:1826-30.
55. Morrison MF, Kallan MJ, Ten Have T, Katz I, Tweedy K, Battistini M. Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial. Biol Psychiatr 2004;55:406-12.
56. Rausch JL, Parry BL. Treatment of premenstrual mood symptoms. Psychiatr Clin North Am 1993;16:829-39.
57. Sherwin BB. The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab 1991;72:336-43.
58. Sherwin BB, Gelfand MM. Sex steroids and affect in the surgical menopause: a double-blind, cross-over study. Psychoneuroendocrinology 1985;10:325-35.
59. Cohen LS, Soares CN, Poitras JR, Prouty J, Alexander AB, Shifren JL. Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report. Am J Psychiatr 2003;160:1519-22.
60. Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatr 2001;58:529-34.
61. Klaiber EL, Broverman DM, Vogel W, Peterson LG, Snyder MB. Relationships of serum estradiol levels, menopausal duration, and mood during hormonal replacement therapy. Psychoneuroendocrinology 1997;22:549-58.
62. Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW. Transdermal oestrogen for treatment of severe postnatal depression. Lancet 1996;347:930-3.
63. Saletu B, Brandstatter N, Metka M, Stamenkovic M, Anderer P, Semlitsch HV etal. Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with transdermal oestradiol therapy in menopausal depression. Psychopharmacology 1995;122:321-9.
64. Yaffe K, Sawaya G, Lieberburg I, Grady D. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 1998;279:688-95.
65. Dunkin J, Rasgon N, Wagner-Steh K, David S, Altshuler L, Rapkin A. Reproductive events modify the effects of estrogen replacement therapy on cognition in healthy postmenopausal women. Psychoneuroendocrinology 2005;30:284.
66. Woolley CS, McEwen BS. Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J Comp Neurol 1993;336:293-306.
67. Dubai DB, Zhu H, Yu J, Rau SW, Shughrue PJ, Merchenthaler I, Kindy MS, Wise PM. Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc Nad Acad Sci USA 2001;98:1952-64.
68. Rabbani O, Panickar KS, Rajakumar G, King MA, Bodor N, Meyer EM et al. 17 beta-estradiol attenuates fimbrial lesion-induced decline of ChAT-immunoreactive neurons in the rat medial septum. Exp Neurol 1997;146:179-86.
69. Simpkins JW, Rajakumar G, Zhang YQ, Simpkins CE, Greenwald D, Yu CJ et al. Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J Neurosurg 1997;87:724-30.
70. Sohrabji F, Peeples KW, Marroquin OA. Local and cortical effects of olfactory bulb lesions on trophic support and cholinergic function and their modulation by estrogen. J Neurobiol 2000;45:61-74.
71. Gould E, Woolley CS, Frankfurt M, McEwen BS. Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J Neurosci 1990;10:1286-91.
72. MacLusky NJ, Luine VN, Hajszan T, Leranth C. The 17alpha and 17beta isomers of estradiol both induce rapid spine synapse formation in the CA1 hippocampal subfield of ovariectomized female rats. Endocrinology 2005;146:287-93.
73. Woolley CS, Gould E, Frankfurt M, McEwen BS. Naturally occurring fluctuation in dendritic spine density on adult hippocampal pyramidal neurons. J Neurosci 1990;10:4035-9.
74. Duman RS, Nakagawa S, Malberg J. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology 2001;25:836-44.
75. Gibbs RB. Levels of trkA and BDNF mRNA, but not NGF mRNA, fluctuate across the estrous cycle and increase in response to acute hormone replacement. Brain Res 1998;787:259-68.
76. Gibbs RB. Treatment with estrogen and progesterone affects relative levels of brain-derived neurotrophic factor mRNA and protein in different regions of the adult rat brain. Brain Res 1999;844:20-7.
77. Walf AA, Frye CA. Estradiol's effects to reduce anxiety and depressive behavior may be mediated by estradiol dose and restraint stress. Neuropsychopharmacology 2005;30:1288-301.
78. Walf AA, Frye CA. Administration of estrogen receptor beta-specific selective estrogen receptor modulators to the hippocampus decrease anxiety and depressive behavior of ovariectomized rats. Pharmacol Biochem Behav 2007;86:407-14.
79. Bowman RE, Ferguson D, Luine VN. Effects of chronic restraint stress and estradiol on open field activity, spatial memory, and monoaminergic neurotransmitters in ovariectomized rats. Neuroscience 2002;113: 401-10.
80. Frick KM, Fernandez SM, Bulinski SC. Estrogen replacement improves spatial reference memory and increases hippocampal synaptophysin in aged female mice. Neuroscience 2002;115:547-58.
81. Frye CA, Rhodes ME, Dudek B. Estradiol to aged female or male mice improves learning in inhibitory avoidance and water maze tasks. Brain Res 2005; 1036:101-8.
82. Frye CA, Rhodes ME. Enhancing effects of estrogen on inhibitory avoidance performance may be in part independent of intracellular estrogen receptors in the hippocampus. Brain Res 2002;956:285-93.
83. Gibbs RB, Gabor R, Cox T, Johnson DA. Effects of raloxifene and estradiol on hippocampal acetylcholine release and spatial learning in the rat. Psychoneuroendocrinology 2004;29:741-8.
84. Li C, Brake WG, Romeo RD, Dunlop JC, Gordon M, Buzescu R et al. Estrogen alters hippocampal dendritic spine shape and enhances synaptic protein immunoreactivity and spatial memory in female mice. Proc Nad Acad Sci 2004;101:2185-90.
85. Luine VN, Jacome LF, Maclusky NJ. Rapid enhancement of visual and place memory by estrogens in rats. Endocrinology 2003;144:2836-44.
86. Packard MG. Post-training estrogen and memory modulation. Horm Behav 1998;34:126-39.
87. Rhodes ME, Frye CA. Estrogen has mnemonic-enhancing effects in the inhibitory avoidance task. Pharmacol Biochem Behav 2004;78:551-8.
88. Greco B, Blasberg ME, Kosinski EC, Blaustein JD. Response of ERalpha-IR and ERbeta-IR cells in the forebrain of female rats to mating stimuli. Horm Behav 2003;43:444-53.
89. Greco B, Lubbers LS, Blaustein JD. Estrogen receptor beta messenger ribonucleic acid expression in the forebrain of proestrous, pregnant, and lactating female rats. Endocrinology 2003;144:1869-75.
90. Insel TR. Regional induction of c-fos-like protein in rat brain after estradiol administration. Endocrinology 1990;126:1849-53.
91. Nishizuka M, Arai Y. Synapse formation in response to estrogen in the medial amygdala developing in the eye. Proc Nad Acad Sci 1982;79:7024-6.
92. Frye CA, Walf AA. Estrogen and/or progesterone systemically or to the amygdala can have anxiety, fear, and pain reducing effects in ovariectomized rats. Behav Neurosci 2004;118:306-13.
93. Ellermeier W, Westphal W. Gender differences in pain ratings and pupil reactions to painful pressure stimuli. Pain 1995;61:435-9.
94. Ferrini MG, Grillo CA, Piroli G, de Kloet ER, De Nicola AF. Sex difference in glucocorticoid regulation of vasopressin mRNA in the paraventricular hypothalamic nucleus. Cell Mol Neurobiol 1997;17:671-86.
95. Hinojosa-Laborde C, Chapa I, Lange D, Haywood JR. Gender differences in sympathetic nervous system regulation. Clin Exp Pharmacol Physiol 1999;26: 122-6.
96. Jezová D, Juránková E, Mosnárová A, Kriska M, Skultétyová I. Neuroendocrine response during stress with relation to gender differences. Acta Neurobiol Exp (Wars) 1996;56:779-85.
97. Rhodes ME, Rubin RT Functional sex differences ('sexual diergism') of central nervous system cholinergic systems, vasopressin, and hypothalamic-pituitary-adrenal axis activity in mammals: a selective review. Brain Res Brain Res Rev 1999;30:135-5.
98. Koehl M, Darnaudery M, Dulluc J, Van Reeth O, Le Moal M, Maccari S. Prenatal stress alters circadian activity of hypothalamo-pituitary-adrenal axis and hippocampal corticosteroid receptors in adult rats of both gender. J Neurobiol 1999;40:302-15.
99. McCormick CM, Smythe JW, Sharma S, Meaney MJ. Sex-specific effects of prenatal stress on hypothalamic-pituitary-adrenal responses to stress and brain glucocorticoid receptor density in adult rats. Brain Res Dev Brain Res 1995;84:55-61.
100. Szuran TF, Pliska V, Pokorny J, Welzl H. Prenatal stress in rats: effects on plasma corticosterone, hippocampal glucocorticoid receptors, and maze performance. Physiol Behav 2000;71:353-62.
101. Frye CA, Wawrzycki J. Effect of prenatal stress and gonadal hormone condition on depressive behaviors of female and male rats. Horm Behav 2003;44:319-26.
102. Sternberg WF. Sex differences in the effects of prenatal stress on stress-induced analgesia. Physiol Behav 1999;68:63-72.
103. Takahashi LK, Haglin C, Kalin NH. Prenatal stress potentiates stress-induced behavior and reduces the propensity to play in juvenile rats. Physiol Behav 1992;51:319-23.
104. Weinstock M, Madina E, Maor GI, Rosen H, McEwen BS. Prenatal stress selectively alters the reactivity of the hypothalamic-pituitary adrenal system in the female rat. Brain Res 1992;595:195-200.
105. Weinstock M. Does prenatal stress impair coping and regulation of hypothalamic-pituitary-adrenal axis? Neurosci Biobehav Rev 1997;21:1-10.
106. Schmitz C, Rhodes ME, Bludau M, Kaplan S, Ong P, Ueffing I et al. Depression: reduced number of granule cells in the hippocampus of female, but not male, rats due to prenatal restraint stress. Mol Psychiatr 2002;7:810-3.
107. Carey MP, Deterd CH, de Koning J, Heimerhorst F, de Kloet ER. The influence of ovarian steroids on hypothalamic-pituitary-adrenal regulation in the female rat. J Endocrinol 1995;144:311-21.
108. Figueiredo HF, Dolgas CM, Herman JP. Stress activation of cortex and hippocampus is modulated by sex and stage of estrus. Endocrinology 2002;143:2534-40.
109. Frye CA, Bayon LE. Mating stimuli influence endogenous variations in the neurosteroids 3alpha, 5alpha-THP and 3alpha-Diol. Neuroendocinol 1999;11:839-47.
110. Viau V, Meaney MJ. Variations in the hypothalamic-pituitary-adrenal response to stress during the estrous cycle in the rat. Endocrinology 1991;129:2503-11.
111. Roca CA, Schmidt PJ, Altemus M, Deuster P, Danaceau MA, Putnam K et al. Differential menstrual cycle regulation of hypothalamic-pituitary- adrenal axis in women with premenstrual syndrome and controls. J Clin Endocrinol Metab 2003;88:3057-63.
112. Patchev VK, Hassan AH, Holsboer DF, Almeida OF. The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus. Neuropsychopharmacology 1996;15:533-40.
113. Küppers E, Pilgrim C, Reisert I. Sex-specific schedule in steroid response of rhombencephalic catecholaminergic neurons in vitro. lnt J Dev Neurosci 1991;9:537-44.
114. Frick KM, Stillner ET, Berger-Sweeney J. Mice are not little rats: species differences in a one-day water maze task. Neuroreport 2000;11:3461-5.
115. Yin H, Fujimoto N, Maruyama S, Asano K. Strain difference in regulation of pituitary tumor transforming gene (PTTG) in estrogen-induced pituitary tumorigenesis in rats. Jpn J Cancer Res 2001;92:1034-40.
116. Burgess LH, Handa RJ. Chronic estrogen-induced alterations in adrenocorticotropin and corticosterone secretion, and glucocorticoid receptor-mediated functions in female rats. Endocrinology 1992;131:1261-9.
117. Dayas CV, Xu Y, Buller KM, Day TA. Effects of chronic oestrogen replacement on stress-induced activation of hypodialamic-pituitary-adrenal axis control pathways. J Neuroendocrinol 2000;12:784-94.
118. Kitay JL. Pituitary adrenal function in the rat after gonadectomy and gonadal hormone replacement. Endocrinology 1963;73:2253-60.
119. McCormick CM, Linkroum W, Sallinen BJ, Miller NW. Peripheral and central sex steroids have differential effects on the HPA axis of male and female rats. Stress 2002;5:235-47.
120. Redei E, Li L, Halasz I, McGivern RF, Aird F. Fast glucocorticoid feedback inhibition of ACTH secretion in the ovariectomized rat: effect of chronic estrogen and progesterone. Neuroendocrinology 1994;60:113-23.
121. Young EA, Altemus M, Parkison V, Shastry S. Effects of estrogen antagonists and agonists on the ACTH response to restraint stress in female rats. Neuropsychopharmacology 2001;25:881-91.
122. Walf AA, Paris JJ, Frye CA. Chronic estradiol replacement to aged female rats reduces anxiety-like and depression-like behavior and enhances cognitive performance. Psychoneuroendocrinology 2009;34:909-16.
123. Daniel JM, Hulst JL, Berbling JL. Estradiol replacement enhances working memory in middle-aged rats when initiated immediately after ovariectomy but not after a long-term period of ovarian hormone deprivation. Endocrinology 2006;147:607-14.
124. Wartella J, Amory E, Lomas LM, Macbeth A, McNamara I, Stevens L et al. Single or multiple reproductive experiences attenuate neurobehavioral stress and fear responses in the female rat. Physiol Behav 2003;79:373-81.
125. Lund TD, Lephart ED. Manipulation of prenatal hormones and dietary phytoestrogens during adulthood alter the sexually dimorphic expression of visual spatial memory. BMC Neurosci 2001;2:21.
126. Walf AA, Frye CA. Effects of two estradiol regimens on anxiety and depressive behaviors and trophic effects in peripheral tissues in a rodent model. Gend Med 2009;6:300-11.
127. Chen J, Adachi N, Liu K, Arai T. The effects of 17beta-estradiol on ischemia-induced neuronal damage in the gerbil hippocampus. Neuroscience 1998;87:817-22.
128. Culmsee C, Vedder H, Ravati A, Junker V, Otto D, Ahlemeyer B et al. Neuroprotection by estrogens in a mouse model of focal cerebral ischemia and in cultured neurons: evidence for a receptor-independent antioxidative mechanism. J Cereb Blood Flow Metab 1999;19:1263-9.
129. Dubai DB, Kashon ML, Pettigrew LC, Ren JM, Finklestein SP, Rau SW et al. Estradiol protects against ischemic injury. J Cereb Blood Flow Metab 1998;18: 1253-8.
130. Dluzen DE, McDermott JL, Liu B. Estrogen alters MPTP-induced neurotoxicity in female mice: effects on striatal dopamine concentrations and release. J Neurochem 1996;66:658-66.
131. Dluzen DE, McDermott JL, Liu B. Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/B1 mice. Neurotoxicol Teratol 1996;18:603.
132. Callier S, Morissette M, Grandbois M, Di Paolo T. Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice. Synapse 2000;37:245-51.
133. Dluzen D. Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine. Brain Res 1997;767:340-4.
134. Frye CA. Estradiol tends to improve inhibitory avoidance performance in adrenalectomized male rats and reduces pyknotic cells in the dentate gyrus of adrenalectomized male and female rats. Brain Res 2001;889:358-63.
135. Hoffman GE, Moore N, Fiskum G, Murphy AZ. Ovarian steroid modulation of seizure severity and hippocampal cell death after kainic acid treatment. Exp Neurol 2003;182:124-34.
136. Walf AA, Rhodes ME, Frye CA. Ovarian steroids enhance object recognition in naturally cycling and ovariectomized, hormone-primed rats. Neurobiol Learn Mem 2006;86:35-46.
137. Rhodes ME, Frye CA. ERbeta-selective SERMs produce mnemonic-enhancing effects in the inhibitory avoidance and water maze tasks. Neurobiol Learn Mem 2006;85:183-91.
138. Walf AA, Frye CA. ERbeta-selective estrogen receptor modulators produce antianxiety behavior when administered systemically to ovariectomized rats. Neuropsychopharmacology 2005;30:1598-609.
139. Moriarty K, Kim KH, Bender JR. Minireview: estrogen receptor-mediated 1rapid signaling. Endocrinology 2006;147:5557-63.
140. Prossnitz ER, Arterburn JB, Sklar LA. GPR30: A G protein-coupled receptor for estrogen. Mol Cell Endocrinol 2007;138:265-6.
141. Thomas P, Yang Y, Filardo EJ, Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 2005;146:624-32.
142. Brailoiu E, Dun SL, Brailoiu GC, Mizuo K, Sklar LA, Oprea TI et al. Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system. J Endocrinol 2007;193: 311-21.
143. Bologa CG, Revankar CM, Young SM, Edwards BS, Arterburn JB, Kiselyov AS et al. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol 2006;2:207-12.
144. Rewal M, Jung ME, Simpkins JW. Role of the GABA-A system in estrogen-induced protection against brain lipid peroxidation in ethanol-withdrawn rats. Alcohol Clin Exp Res 2004;28:1907-15.
145. Birzniece V, Bäckström T, Johansson IM, Lindblad C, Lundgren P, Löfgren Met al. Neuroactive steroid effects on cognitive functions with a focus on the serotonin and GABA systems. Brain Res Rev 2006;51:212-39.
146. Adams MM, Oung T, Morrison JH, Gore AC. Length of postovariectomy interval and age, but not estrogen replacement, regulate N-methyl-D-aspartate receptor mRNA levels in the hippocampus of female rats. Exp Neurol 2001;170:345-56.
147. Adams MM, Fink SE, Janssen WG, Shah RA, Morrison JH. Estrogen modulates synaptic N-mediyl-D-aspartate receptor subunit distribution in the aged hippocampus. J Comp Neurol 2004;474:419-26.
148. McEwen B, Akama K, Alves S, Brake WG, Bulloch K, Lee S et al. Tracking the estrogen receptor in neurons: implications for estrogen-induced synapse formation. Proc Nad Acad Sci U S A 2001;98:7093-100.
149. Feldker DE, Datson NA, Veenema AH, Meulmeester E, de Kloet ER, Vreugdenhil E. Serial analysis of gene expression predicts structural differences in hippocampus of long attack latency and short attack latency mice. Eur J Neurosci 2003;17:379-87.
150. Hasegawa S, Furuichi T, Yoshida T, Endoh K, Kato K, Sado M et al. Transgenic up-regulation of alpha-CaMKII in forebrain leads to increased anxiety-like behaviors and aggression. Mol Brain 2009;2:6.
151. Nomura M, Durbak L, Chan J, Smithies O, Gustafsson JA, Korach KS et al. Genotype/age interactions on aggressive behavior in gonadally intact estrogen receptor beta knockout (betaERKO) male mice. Horm Behav 2002;41:288-96.
152. Nomura M, Andersson S, Korach KS, Gustafsson JA, Pfaff DW, Ogawa S. Estrogen receptor-beta gene disruption potentiates estrogen-inducible aggression but not sexual behaviour in male mice. Eur J Neurosci 2006;23:1860-8.
153. Bäckström T, Andersson A, Andreé L, Birzniece V, Bixo M1 Björn I et al. Pathogenesis in menstrual cycle-linked CNS disorders. Ann N Y Acad Sci 2003;1007: 42-53.
154. Endicott J, Amsterdam J, Eriksson E, Frank E, Freeman E, Hirschfeld R et al. Is premenstrual dysphoric disorder a distinct clinical entity? J Woman's Healdi Gend-Based Med 1999;8:663-79.
155. Glick ID, Bennett SE. Psychiatric complications of progesterone and oral contraceptives. J Clin Psychopharmacol 1981;1:350-67.
156. Markou A, Duka T, Prelevic GM. Estrogens and brain function. Hormones (Athens) 2005;4:9-17.
157. Pearlstein TB, Bachmann G A, Zacur HA, Yonkers KA. Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation. Contraception 2005;72:414-21.
158. Rapkin AJ, Mikacich JA, Moatakef-Imani B, Rasgon N. The clinical nature and formal diagnosis of premenstrual, postpartum, and perimenopausal affective disorders. Curr Psychiatry Rep 2002;4:419-28.
159. Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 1998;33:209-16.
160. Hammarbäck S, Damber JE, Bäckström T. Relationship between symptom severity and hormone changes in women with premenstrual syndrome. J Clin Endocrinol Metab 1989;68:125-30.
161. Seippel L, Bäckström T. Luteal-phase estradiol relates to symptom severity in patients with premenstrual syndrome. J Clin Endocrinol Metab 1998;83:1988-92.
162. Segebladh B, Borgström A, Odlind V, Bixo M, Sundström-Poromaa I. Prevalence of psychiatric disorders and premenstrual dysphoric symptoms in patients with experience of adverse mood during treatment with combined oral contraceptives. Contraception 2009;79:50-5.
163. Cagnacci A, Arangino S, Baldassari F, Alessandrini C, Landi S, Volpe A. A comparison of the central effects of different progestins used in hormone replacement therapy. Maturitas 2004;48:456-62.
164. Vashisht A, Wadsworth F, Carey A, Carey B, Studd J. A study to look at hormonal absorption of progesterone cream used in conjunction with transdermal estrogen. Gynecol Endocrinol 2005;21:101-5.
165. Contreras CM, Molina M, Saavedra M, Martinez-Mota L. Lateral septal neuronal firing rate increases during proestrus-estrus in the rat. Physiol Behav 2000;68: 279-84.
166. Frye CA, Walf AA. Changes in progesterone metabolites in the hippocampus can modulate open field and forced swim test behavior of proestrous rats. Horm Behav 2002;41:306-15.
167. Marcondes FK, Miguel KJ, Melo LL, Spadari-Bratfisch RC. Estrous cycle influences the response of female rats in the elevated plus-maze test. Physiol Behav 2001;74:435-40.
168. Marvan ML, Chavez-Chavez L, Santana S. Clomipramine modifies fluctuations of forced swimming immobility in different phases of the rat estrous cycle. Arch Med Res 1996;27:83-6.
169. Bitran D, Foley M, Audette D, Leslie N, Frye CA. Activation of peripheral mitochondrial benzodiazepine receptors in the hippocampus stimulates allopregnanolone synthesis and produces anxiolytic-like effects in the rat. Psychopharmacology 2000;151:64-71.
170. Guidotti A, Costa E. Can the antidysphoric and anxiolytic profiles of selective serotonin reuptake inhibitors be related to their ability to increase brain 3α,5α-tetrahydroprogesterone (allopregnanolone) availability? Biol Psychiatry 1998;44:865-73.
171. Jain NS, Hirani K, Chopde CT. Reversal of caffeine-induced anxiety by neurosteroid 3-α-hydroxy-5-α-pregnane-20-one in rats. Neuropharmacology 2005;48: 627-38.
172. Becker JB, Cha JH. Estrous cycle-dependent variation in amphetamine-induced behaviors and striatal dopamine release assessed with microdialysis. Behav Brain Res 1989;35:117-25.
173. A receptor. Brain Res 1991;561:157-61.
174. a receptor in the amygdala after progesterone withdrawal. Eur J Neurosci 2003;17:641-8.
175. Frye CA, Petralia SM, Rhodes ME. Estrous cycle and sex differences in performance on anxiety tasks coincide with increases in hippocampal progesterone and 3alpha,5alpha-THP. Pharmacol Biochem Behav 2000;67:587-96.
176. Walf AA, Frye CA. A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior. Neuropsychopharmacology 2006;31:1097-111.
177. Frye CA, Walf AA. Hippocampal 3·,5·-THP may alter depressive behavior of pregnant and lactating rats. Pharmacol Biochem Behav 2004;78:531-40.
178. Walf AA, Sumida K, Frye CA. Inhibiting 5·-reductase in the amygdala attenuates antianxiety and antidepressive behavior of naturally receptive and hormone-primed ovariectomized rats. Psychopharmacology (Berl) 2006;186:302-11.
179. Zimmerberg B, Brunelli SA, Fluty AJ, Frye CA. Differences in affective behaviors and hippocampal allopregnanolone levels in adult rats of lines selectively bred for infantile vocalizations. Behav Brain Res 2005;159:301-11.
180. Frye CA. 2009. Hormonal influences on seizures: basic neurobiology. In: Gidal BE, Harden CL, editors. Epilepsy in women: the scientific basis for clinical management. International Review of Neurobiology. New York, NY: Academic Press; 2008.
181. Patchev VK, Shoaib M, Holsboer F, Almeida OF. The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus. Neuroscience 1994; 62:265-71.
182. Holmes MM, Rosen GJ, Jordan CL, de Vries GJ, Goldman BD, Forger NG. Social control of brain morphology in a eusocial mammal. Proc Natl Acad Sci U S A 2007;104:10548-52.
183. Mairesse J, Viltart O, Salome N, Giuliani A, Catalani A, Casolini P et al. Prenatal stress alters the negative correlation between neuronal activation in limbic regions and behavioral responses in rats exposed to high and low anxiogenic environments. Psychoneuroendocrinology 2007;32:765-76.
184. Meaney MJ, Aitken DH, Sharma S, Viau V. Basal ACTH, corticosterone and corticosterone-binding globulin levels over the diurnal cycle, and age-related changes in hippocampal type I and type II corticosteroid receptor binding capacity in young and aged, handled and non-handled rats. Neuroendocrinology 1992;55:204-13.
185. Seckl JR, 2008 Prenatal glucocorticoids and long-term programming. Eur J Endocrinol 2004;151(Suppl 3): U49-62.
186. Dubrovsky BO. Steroids, neuroactive steroids and neurosteroids in psychopathology. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:169-92.
187. Yehuda R, Teicher MH, Seckl JR, Grossman RA, Morris A, Bierer LM. Parental posttraumatic stress disorder as a vulnerability factor for low Cortisol trait in offspring of holocaust survivors. Arch Gen Psychiatry 2007;64:1040-8.
188. Walf AA, Frye CA. Estradiol decreases anxiety behavior and enhances inhibitory avoidance and gestational stress produces opposite effects. Stress 2007;10:251-60.
189. Frye CA, Orecki ZA. Prenatal stress alters reproductive responses of rats in behavioral estrus and paced mating of hormone-primed rats. Horm Behav 2002;42: 472-83.
190. Rahimi-Ardabili B, Pourandarjani R, Habibollahi P, Mualeki A. Finasteride induced depression: a prospective study. BMC Clin Pharmacol 2006;6:7.
191. Altomare G, Capella GL. Depression circumstantially related to the administration of finasteride for androgenetic alopecia. J Dermatol 2002;29:665-9.
192. Frye CA, Sumida K, Lydon JP, O'Malley BW, Pfaff DW. Mid-aged and aged wild-type and progestin receptor knockout (PRKO) mice demonstrate rapid progesterone and 3alpha,5alpha-THP-facilitated lordosis. Psychopharmacology (Berl) 2006;185:423-32.
193. Frye CA, Walf AA, Rhodes ME, Harney JP. Progesterone enhances motor, anxiolytic, analgesic, and antidepressive behavior of wild-type mice, but not those deficient in type 15·-reductase. Brain Res 2004;1004:116-24.
194. Rhodes ME, McCormick CM, Frye CA. 3alpha,5alpha-THP mediates progestins' effects to protect against adrenalectomy-induced cell death in the dentate gyrus of female and male rats. Pharmacol Biochem Behav 2004;78:505-12.
195. Koenig HL, Schumacher M, Ferzaz B, Thi AN, Ressouches A, Guennoun R et al. Progesterone synthesis and myelin formation by Schwann cells. Science 1995;268:1500-3.
196. Dubrovsky B, Tatarinov A, Gijsbers K, Harris J, Tsiodras A. Effects of arginine-vasopressin (AVP) on long-term potentiation in intact anesthetized rats. Brain Res Bull 2003;59:467-72.
197. Stachenfeld NS. Sex hormone effects on body fluid regulation. Exerc Sport Sci Rev 2008;36:152-9.
198. Easterbrook JD, Klein SL. Corticosteroids modulate Seoul virus infection, regulatory T-cell responses and matrix metalloprotease 9 expression in male, but not female, Norway rats. J Gen Virol 2008;89(Pt 11): 2723-30.
199. Girdler SS, Klatzkin R. Neurosteroids in the context of stress: Implications for depressive disorders. Pharmacol Therapeutics 2007;116:125-39.
200. Romeo E, Ströhle A, Spalletta G, di Michele F, Hermann B, Holsboer F et al. Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry 1998;155:910-3.
201. Matsumoto K, Pinna G, Puia G, Guidotti A, Costa E. Social isolation stress-induced aggression in mice: A model to study the pharmacology of neurosteroidogenesis. Stress: Int J Biol Stress 2005;8:85-93.
202. Benekareddy M, Mehrotra P, Kulkarni VA, Ramakrishnan P, Dias BG, Vaidya VA. Antidepressant treatments regulate matrix metalloproteinases-2 and -9 (MMP-2/MMP-9) and tissue inhibitors of the metalloproteinases (TIMPS 1-4) in the adult rat hippocampus. Synapse 2008;62:590-600.
203. Goldman S, Lovett DH, Shalev E. Mechanisms of matrix metalloproteinase-2 (mmp-2) transcriptional repression by progesterone in jar choriocarcinoma cells. Reprod Biol Endocrinol 2009;9,7:41.
204. Howell S, Shalet S. Testosterone deficiency and replacement. Horm Res 2001;56(Suppl 1):86-92.
205. Kaminetsky JC. Benefits of a new testosterone gel formulation for hypogonadal men. Clin Cornerstone 2005;7(Suppl 4):S8-S12.
206. Davis S. Testosterone deficiency in women. J Reprod Med 2001;46:291-6.
207. Lund BC, Bever-Stille KA, Perry PJ. Testosterone and andropause: the feasibility of testosterone replacement therapy in elderly men. Pharmacotherapy 1999;19:951-6.
208. Orengo CA, Fullerton G, Tan R. Male depression: a review of gender concerns and testosterone therapy. Geriatrics 2004;59:24-30.
209. Seidman SN. Testosterone deficiency and mood in aging men: pathogenic and therapeutic interactions. World J Biol Psychiatry 2003;4:14-20.
210. Sternbach H. Age-associated testosterone decline in men: clinical issues in psychiatry. Am J Psychiatry 1998;155:1310-18.
211. Beer TM, Bland LB, Bussiere JR, Neiss MB, Wersinger EM, Garzotto M et al. Testosterone loss and estradiol administration modify memory in men. J Urol 2006;175:130-5.
212. Janowsky JS. The role of androgens in cognition and brain aging in men. Neuroscience 2006;138:1015-102.
213. Cafri G, van den Berg P, Thompson JK. Pursuit of muscularity in adolescent boys: relations among biopsychosocial variables and clinical outcomes. J Clin Child Adolesc Psychol 2006;35:283-91.
214. Delhez M, Hansenne M, Legros JJ. Andropause and psychopathology: minor symptoms rather than pathological ones. Psychoneuroendocrinology 2003;28:863-74.
215. Edinger KL, Frye CA. Sexual experience of male rats influences anxiety-like behavior and androgen levels. Physiol Behav 2007;92:443-53.
216. Buddenberg TE, Komorowski M, Ruocco LA, Silva MA, Topic B. Attenuating effects of testosterone on depressive-like behavior in the forced swim test in healthy male rats. Brain Res Bull 2009;79:182.
217. Osborne DM, Edinger K, Frye CA. Chronic administration of androgens with actions at estrogen receptor beta have anti-anxiety and cognitive-enhancing effects in male rats. Age (Dordr) 2009;31:191-8.
218. Frye CA, Walf AA. Depression-like behavior of aged male and female mice is ameliorated with administration of testosterone or its metabolites. Physiol Behav 2009;97:266-9.
219. Edinger KL, Frye CA. Testosterone's analgesic, anxiolytic, and cognitive-enhancing effects may be due in part to actions of its 5alpha-reduced metabolites in the hippocampus. Behav Neurosci 2004;118:1352-64.
220. Edinger KL, Frye CA. Testosterone's anti-anxiety and analgesic effects may be due in part to actions of its 5alpha-reduced metabolites in the hippocampus. Psychoneuroendocrinology 2005;30:418-30.
221. Edinger KL, Frye CA. Intrahippocampal administration of an androgen receptor antagonist, flutamide, can increase anxiety-like behavior in intact and DHT-replaced male rats. Horm Behav 2006;50:216-22.
222. Frye CA, Edinger KL, Seliga AM, Wawrzycki JM. 5alpha-reduced androgens may have actions in the hippocampus to enhance cognitive performance of male rats. Psychoneuroendocrinology 2004;29: 1019-27.
223. Frye CA, Edinger KL Testosterone's metabolism in the hippocampus may mediate its anti-anxiety effects in male rats. Pharmacol Biochem Behav 2004;78: 473-81.
224. Frye CA, McCormick CM. Androgens are neuroprotective in the dentate gyrus of adrenalectomized female rats. Stress 2000;3:185-94.
225. Ramsden M, Shin TM, Pike CJ. Androgens modulate neuronal vulnerability to kainate lesion. Neuroscience 2003;122:573-8.
226. Frye CA, Reed TA. Androgenic neurosteroids: anti-seizure effects in an animal model of epilepsy. Psychoneuroendocrinology 1998;23:385-99.
227. Rhodes ME, Frye CA. Androgens in the hippocampus can alter, and be altered by, ictal activity. Pharmacol Biochem Behav 2004;78:483-93.